• 1. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxamides and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives Indolecarboxamides and derivatives

Introduction to 1-methyl-1H-Indole-2-carboxamide (CAS No. 56297-43-9)

1-methyl-1H-Indole-2-carboxamide, identified by its Chemical Abstracts Service (CAS) number 56297-43-9, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indole derivatives family, a class of molecules widely recognized for their diverse biological activities and pharmacological potential. The structural motif of indole, characterized by a benzene ring fused to a pyrrole ring, serves as a cornerstone in the design of bioactive molecules, making derivatives like 1-methyl-1H-Indole-2-carboxamide particularly intriguing for researchers.

The chemical structure of 1-methyl-1H-Indole-2-carboxamide consists of an indole core substituted with a methyl group at the 1-position and an amide functional group at the 2-position. This specific substitution pattern imparts unique electronic and steric properties to the molecule, influencing its interactions with biological targets. The amide group, in particular, is a common pharmacophore in drug discovery, often contributing to binding affinity and metabolic stability. The presence of the methyl group at the 1-position further modulates the molecule's physicochemical properties, such as solubility and lipophilicity, which are critical factors in drug development.

In recent years, there has been a surge in research focused on indole derivatives due to their broad spectrum of biological activities. These activities range from antimicrobial and anti-inflammatory effects to potential applications in cancer therapy and neurodegenerative diseases. The structural versatility of indole derivatives allows for the design of molecules that can interact with various biological pathways, making them valuable candidates for therapeutic intervention.

One of the most compelling aspects of 1-methyl-1H-Indole-2-carboxamide is its potential as a lead compound for drug development. Its indole scaffold is reminiscent of several known bioactive molecules, suggesting that it may possess similar pharmacological properties. For instance, indole derivatives have been extensively studied for their role in modulating immune responses and inflammation. The amide group in 1-methyl-1H-Indole-2-carboxamide could potentially engage with protease enzymes or signaling pathways involved in these processes.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding modes of small molecules like 1-methyl-1H-Indole-2-carboxamide with high precision. These tools have been instrumental in identifying potential drug candidates by virtual screening and docking studies. By leveraging these technologies, scientists have been able to uncover novel interactions between 1-methyl-1H-Indole-2-carboxamide and biological targets, paving the way for new therapeutic strategies.

The synthesis of 1-methyl-1H-Indole-2-carboxamide is another area of active research. Efficient synthetic routes are crucial for producing sufficient quantities of the compound for both preclinical studies and commercial development. Researchers have explored various synthetic methodologies, including multi-step organic transformations and catalytic processes, to optimize yield and purity. These efforts are essential for ensuring that 1-methyl-1H-Indole-2-carboxamide can be produced reliably and cost-effectively on an industrial scale.

In vitro studies have begun to elucidate the biological profile of 1-methyl-1H-Indole-2-carboxamide, revealing promising activities in several disease models. For example, preliminary data suggest that this compound may exhibit inhibitory effects on certain enzymes implicated in cancer progression. Additionally, its ability to modulate immune cell function has been explored, indicating potential applications in treating autoimmune disorders or infections. These findings underscore the importance of further investigating 1-methyl-1H-Indole-2-carboxamide as a therapeutic agent.

The pharmacokinetic properties of 1-methyl-1H-Indole-2-carboxamide are also under scrutiny to assess its suitability as a drug candidate. Parameters such as absorption, distribution, metabolism, excretion (ADME), and toxicity (TOX) are critical determinants of a molecule's clinical efficacy and safety profile. Advanced analytical techniques, including high-performance liquid chromatography (HPLC) and mass spectrometry (MS), have been employed to characterize these properties accurately. Understanding these aspects will be crucial for designing effective dosing regimens and minimizing potential side effects.

One notable aspect of indole derivatives is their ability to cross biological membranes due to their lipophilic nature. This property makes them attractive candidates for oral administration, which is often preferred by patients due to convenience. However, achieving optimal bioavailability while maintaining stability throughout the digestive tract remains a challenge. Researchers are exploring strategies such as prodrug formulations or encapsulation techniques to enhance the delivery of 1-methyl-1H-Indole-2-carboxamide.

The role of 1-methyl-1H Ind ole - 2 - carbox amid e in modulating neurological pathways has also sparked interest among scientists studying neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Indole derivatives have shown promise in preclinical models by protecting against neuronal damage and improving cognitive function. The amide group in 56297 - 43 - 9 could potentially interact with neurotransmitter receptors or enzymes involved in these processes, offering a novel approach to treatment.

Environmental considerations are also increasingly becoming part of drug development strategies. Sustainable synthesis methods that minimize waste and reduce environmental impact are being prioritized by pharmaceutical companies worldwide. Innovations such as green chemistry principles and biocatalysis are being integrated into synthetic routes for compounds like 56297 - 43 - 9, ensuring that their production aligns with global sustainability goals.

The future direction of research on 56297 - 43 - 9 appears promising, with several avenues yet to be fully explored. Further investigation into its mechanism(s) of action will provide deeper insights into its therapeutic potential across multiple disease indications. Collaborative efforts between academia and industry will be essential for translating preclinical findings into clinical trials and ultimately bringing this compound into medical practice.

In conclusion,56297 - 43 - 9, represents an exciting opportunity within pharmaceutical research due to its structural features and demonstrated biological activities . As our understanding grows , so too does our appreciation fo rthe versatility o find ole derivatives like this one . Continued study promises not only new insights into disease mechanisms but also innovative treatments that could benefit patients worldwide . p >

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)